REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search-icon
Covid-19

Antibody Levels Remain High Two Months After Receiving the Second Dose of the COVID-19 Vaccine

Antibody
Sheba study indicates only a minor, expected decline in antibody levels among recipients of the Pfizer-BioNTech vaccine

Two months after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine, 2,500 of Sheba Medical Center’s employees displayed high blood antibody levels according to a new Sheba study. While a minor decline in blood antibody levels was observed, Prof. Gili Regev-Yochay, Director of the Infectious Diseases Unit at Sheba, says that “this drop was expected, and should not cause alarm.”

Prof. Regev-Yochay added: “We observed blood antibody levels that were much higher than the required threshold in most of the study’s participants. The few participants that displayed a more significant drop are currently being examined to determine whether this drop is indicative of decreased protection against COVID-19 infection.

The initial study on the efficacy of the Pfizer-BioNTech vaccine also included the hospital staff and has shown that the initial results have shown high-level protection against the COVID-19. The study will continue, and participants will be tested again to determine blood antibody levels 3 months after receiving the second vaccine jab.

Related
Sheba DUNS 100

For The Second Consecutive Year: Sheba Tops the Healthcare Sector on Dun & Bradstreet’s List of Leading Organizations

Dun & Bradstreet, the world’s foremost commercial data company, ranked 71 doctors from Sheba Medical Center in its list of the top Israeli clinical experts.…
Read More

Ayelet’s Miracle: The First Woman to Conceive Four Children Following Ovarian Tissue Cryopreservation

At 21, Ayelet Rozenberg was diagnosed with Hodgkin’s lymphoma. Facing aggressive therapies necessary to save her life, Ayelet feared she would never be able to…
Read More
bowel disease
News Sep 07.

Sheba Partners with Biomica to Advance Inflammatory Bowel Disease Care

As part of the new collaboration, Sheba and Biomica will engage in joint microbiome clinical research to develop better treatments for inflammatory bowel disease (IBD)…
Read More